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Introduction {#sec001}
============

Genetic studies have uncovered hundreds of candidate *loci* \[[@pone.0121464.ref001], [@pone.0121464.ref002]\] associated with Autism Spectrum Disorders (ASDs). Despite remarkable progress, one major outstanding challenge is identification of shared biological pathways that could contribute to convergent dysfunctions arising from genetic heterogeneity \[[@pone.0121464.ref003], [@pone.0121464.ref004]\]. Fragile X syndrome (FXS), a leading cause of inherited intellectual disability, accounts for 2--5% of autism cases and \~30% of individuals with FXS are diagnosed with autism, suggesting that the conditions may share common pathophysiology \[[@pone.0121464.ref005], [@pone.0121464.ref006]\]. FXS is a monogenic disorder that arises from abnormal expansion of a tri-nucleotide repeat in the 5'-untranslated region of the X-linked Fmr1 gene, leading to transcriptional silencing that results in loss of Fragile X Mental Retardation Protein (FMRP) expression \[[@pone.0121464.ref007]\]. FMRP is an RNA-binding protein that binds to \>4% of brain transcripts \[[@pone.0121464.ref008], [@pone.0121464.ref009]\] to regulate mRNA translation, trafficking and stability \[[@pone.0121464.ref007], [@pone.0121464.ref010]--[@pone.0121464.ref012]\]. FMRP was shown to inhibit mRNA translation \[[@pone.0121464.ref007]\] and in its absence basal protein synthesis is abnormally elevated \[[@pone.0121464.ref013], [@pone.0121464.ref014]\]. Profound abnormalities in intracellular signaling pathways have also been observed in cells lacking FMRP. Cyclic AMP production is decreased \[[@pone.0121464.ref015], [@pone.0121464.ref016]\] whereas basal activities of Ras \[[@pone.0121464.ref017]\], extracellular signal-regulated protein kinases 1/2 (ERK1/2; \[[@pone.0121464.ref018], [@pone.0121464.ref019]\]), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K; \[[@pone.0121464.ref020], [@pone.0121464.ref021]\]) and mammalian target of rapamycin (mTOR \[[@pone.0121464.ref022], [@pone.0121464.ref023]\]) are abnormally enhanced. In contrast, receptor dependent signaling is impaired including signaling by group 1 metabotropic glutamate receptors (Gp1 mGluRs) to ERK1/2 \[[@pone.0121464.ref019]\] and PI3K-AKT-mTOR \[[@pone.0121464.ref022], [@pone.0121464.ref024]\] pathways and signaling by dopamine receptor 1 (D1R) to the cAMP cascade \[[@pone.0121464.ref025]\]. Collectively, these findings suggest that loss of FMRP leads to general deficits in the efficiency and regulation of cellular signaling, dysfunctions that might be common to other disorders in the autism spectrum.

Lipid rafts (also termed membrane rafts) are liquid-ordered regions of the plasma membrane, originating from local enrichment in glycosphingolipids and cholesterol, that recruit selected integral membrane proteins and proteins carrying glycosylphosphatidylinositol (GPI) anchors: in addition, palmitoylated and acylated proteins associate with the inner leaflet of plasma membrane rafts \[[@pone.0121464.ref026], [@pone.0121464.ref027]\]. Lipid rafts are thought to provide transient 'platforms' for receptors and signaling effectors thereby contributing to regulation of cell signaling \[[@pone.0121464.ref028], [@pone.0121464.ref029]\]. Native lipid rafts are plastic, transient, small (\~40--100 nm) membrane subdomains that are not amenable to biochemical purification; description of their putative composition as well as identification of properties shared by proteins endowed with raft affinity have largely originated from the characterization of [d]{.ul}etergent-[r]{.ul}esistant [m]{.ul}embranes (DRMs). DRMs are a collection of buoyant membranes resistant to solubilization by cold, non-ionic detergents and are selectively enriched in cholesterol, glycolipids and raft-associated proteins \[[@pone.0121464.ref030]\]. Importantly, DRMs are amenable to biochemical purification and thus afford a means of assessment of lipid raft composition under basal and perturbed conditions \[[@pone.0121464.ref031]\].

In the central nervous system (CNS), lipid rafts have been implicated in establishment of neuron polarity \[[@pone.0121464.ref032], [@pone.0121464.ref033]\], axon guidance \[[@pone.0121464.ref034]\], dendritogenesis \[[@pone.0121464.ref035]\], spine morphogenesis \[[@pone.0121464.ref036]\] and myelination \[[@pone.0121464.ref037], [@pone.0121464.ref038]\]. Lipid raft composition is remodeled during neuronal differentiation \[[@pone.0121464.ref034]\] and aging \[[@pone.0121464.ref039]\], and is altered in neuropsychiatric conditions \[[@pone.0121464.ref040]\] including Alzheimer's disease \[[@pone.0121464.ref041]\], schizophrenia \[[@pone.0121464.ref042]\], depression \[[@pone.0121464.ref043]\] and Smith-Lemli-Opitz syndrome \[[@pone.0121464.ref044]\]---an autism spectrum disorder \[[@pone.0121464.ref045], [@pone.0121464.ref046]\]. Despite the broad impact of Fmr1 ablation on neuronal signaling, it remains unknown whether the composition of lipid rafts is altered in animal models of FXS. A subset of RNA transcripts predicted to bind FMRP \[[@pone.0121464.ref008]\] encodes proteins critically involved in lipid synthesis and transport: thus, loss of FMRP expression may conceivably affect lipid homeostasis and lipid raft properties.

To examine whether loss of FMRP expression results in alterations in the properties of lipid rafts, we used a systems biology approach based on protein identification and quantification by mass spectrometry. We used [i]{.ul}sobaric [t]{.ul}ags for [r]{.ul}elative and [a]{.ul}bsolute [q]{.ul}uantification (iTRAQ; \[[@pone.0121464.ref047]\]) to label peptides for qualitative and quantitative analysis of the proteome of DRMs purified from mouse brain. By this strategy we uncovered candidate proteins that are differentially represented in the lipid raft proteome of FMR1 knockout mice and linked them by network analysis to specific cellular components and functional pathways, such as axonal processes and myelination, which could be affected by ablation or silencing of Fmr1.

Materials and Methods {#sec002}
=====================

Reagents and animals {#sec003}
--------------------

The following antibodies were used according to manufacturer recommendations: mouse monoclonal antibodies anti-Flotilllin-1 (BD Biosciences), anti-Homer1b/c (Santa Cruz Biotechnology), anti-Ly6h (Abnova) anti-Plp1 (Millipore), anti-Thy-1 (BioLegend), anti-Transferrin receptor 1 (Invitrogen), anti-β-Tubulin (Sigma Aldrich), anti-γ-Tubulin (Sigma Aldrich) and rabbit polyclonal antibodies anti-CaMKIIα/β Cell Signaling Technology) and anti-Gnb2 (Abcam). Mouse anti-Versican core protein (clone 351/24) was obtained from the UC Davis/NIH NeuroMab Facility. Wild type and Fmr1 null (FVB.129P2-*Pde6b* ^*+*^ strain) mice were obtained from The Jackson Laboratories (Bar Harbor, ME) and bred in house. For euthanasia, mice were deeply anesthetized by isoflurane inhalation until insensate and decapitated. All animal procedures were carried out according to protocols approved by the Albert Einstein College of Medicine Institutional Animal Care and Use Committee and in accordance with the Guide for the Care and Use of Laboratory Animals by the United States Public Health Service.

Subcellular fractionation and western blot {#sec004}
------------------------------------------

Cortices (hippocampi removed), hippocampi and cerebella from adult WT and Fmr1 KO mice (\~ five month-old) were homogenized on ice in homogenization buffer of 10 mM Tris-HCl pH 7.4, 5 mM EDTA, 320 mM sucrose, eukaryotic protease inhibitor cocktail and Na~3~VO~4~. Homogenates were centrifuged for 10 min at 800 x *g* to precipitate nuclei and supernatant fraction collected (S1) and centrifuged at 10,000 x *g* for 15 min. The resulting pellet (P2) and supernatant (S2) were separated and solubilized in lysis buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% CHAPS supplemented with protease inhibitor cocktail and Na~3~VO~4~. Analysis of proteins was performed by protein separation by SDS-PAGE followed by immunoblot with specific primary antibodies and detection with horseradish peroxidase-conjugated secondary antibodies as previously described \[[@pone.0121464.ref048]\].

Isolation of detergent resistant membranes (DRM) from mouse brain tissue {#sec005}
------------------------------------------------------------------------

DRM preparation was carried out according to previously described procedures \[[@pone.0121464.ref049]\]. Briefly, adult mice (\~ five to six month-old) were euthanized and microdissected tissue rinsed with saline solution and homogenized with a Dounce tissue grinder in cold homogenization buffer with protease inhibitors. After low speed centrifugation to remove nuclei and residual particulate material, supernatants were spun at 10,000 x *g* at 4ºC and resulting pellets dissolved in cold buffer of 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100 (v/v) and incubated on ice (10 min). Solubilized pellets were adjusted to 40% sucrose and fractionated on discontinuous sucrose gradients by centrifugation at 34,000 rpm (SW40 Ti; Beckman Coulter) for 16 h. Thirteen fractions (1 ml each) were collected from each gradient starting from the top and an aliquot of each analyzed by Western blot.

iTRAQ proteomics {#sec006}
----------------

We carried out proteomic profiling of WT and Fmr1 KO mice using purified DRMs labeled with iTRAQ reagents: samples were processed by Applied Biomics (Hayward, CA) for isotope labeling and analytical mass spectrometry. Briefly, DRMs were purified from freshly dissected cortices (hippocampi removed) from individual mice (three animals per genotype in one experiment and two animals per genotype in two experiments): fractions enriched in DRMs (routinely fractions \# 3, 4, and 5) were combined for each genotype to yield approximately 6 or 9 ml collective volume, depending on number of animals, and concentrated. Equal amounts of protein for WT and Fmr1 KO mice, approximately 6 to 8 μg depending on the preparation, were reduced and alkylated followed by digestion with trypsin and labeling with iTRAQ reagents (AB Sciex) with reporter ions/isobaric tags 114/113 or 118/117. Tagged peptides were combined and fractionated on a nano-LC column and analyzed by MS and MS/MS with ABSCIEX 5800 (AB Sciex). For protein identification, MS/MS spectra were submitted for search of the SwissProt and decoy databases using MASCOT. For each protein hit, only peptides with a confidence interval (C.I.) \>95% were considered. Peptides corresponding to keratin, a potential contaminant, were excluded from final combined analysis of independent experiments. The ratios of peptide quantities expressed as signal intensity ratios of reporter groups for individual peaks were obtained to calculate average ratio(s) for the protein, number of peptides that contributed to the average and the geometric standard deviation. In some instances, a ratio could not be determined because one or more relevant peaks were missing or peptide match was rejected based on confidence interval.

Gene ontology enrichment and protein interaction network analyses {#sec007}
-----------------------------------------------------------------

Gene ontology (GO) analysis was carried out with the Database for Annotation, Visualization and Integrated Discovery (DAVID; \[[@pone.0121464.ref050], [@pone.0121464.ref051]\]). The database was searched using a subset of the brain raft proteome that included 85 genes encoding proteins for which comparative quantitative information was obtained, and used to assess enrichment in particular GO terms. Identified GO terms were grouped based on functional annotation for biological process (GO_BP), cellular component (GO_CC), and molecular function (GO_MF). Functional annotation was carried out according to published protocols \[[@pone.0121464.ref050]\] with default settings and using *Mus musculus* genome as background reference database. Terms with Benjamini Hochberg-corrected *p* value \<0.05 are illustrated. Network analysis was carried out using a query list of four genes encoding proteins that showed differential abundance in the brain raft proteome of Fmr1 KO mice using *Mus musculus* as reference. The query list did not include Tubb2a and Tubb5, encoding tubulin isoforms, to prevent skewing the network and Ly6h due to paucity of information for this gene. Analysis and representation of network connections were carried out with GeneMANIA \[[@pone.0121464.ref052]\] with default settings: predicted connectivity is illustrated by links which reflect degree of confidence of relationships between gene pairs.

Results {#sec008}
=======

Characterization of mouse brain lipid raft proteome {#sec009}
---------------------------------------------------

In neurons, lipid rafts recruit ion channels and ionotropic neurotransmitter receptors, including glutamate and nicotinic acetylcholine receptors, and regulate the activity of metabotropic receptors for neurotransmitters and neuromodulators \[[@pone.0121464.ref053]\]. In Fmr1 null neurons, tonic activity of selected signaling effector proteins and metabotropic functions of Gp1 mGluRs, dopamine and cannabinoid \[[@pone.0121464.ref054]\] receptors among others are dysregulated, but whether the integrity and/or function of lipid rafts are compromised in absence of FMRP is unknown. Here, we set out to determine whether the relative abundance of proteins associated with raft membranes is altered by potential homeostatic changes occurring upon loss of FMRP expression. To examine whether the composition of the brain lipid raft proteome is altered in absence of FMRP, we used a well-characterized animal model of FXS---Fmr1 knockout mice (Fmr1 KO; \[[@pone.0121464.ref055]\]). To this end, we isolated detergent-resistant membranes (DRMs; \[[@pone.0121464.ref049]\]) from the cerebrum of adult wild type (WT) and mutant Fmr1 knockout (Fmr1 KO) mice to recover sufficient material for proteome analysis. We used anti-Flotillin-1 antibodies to identify membrane fractions enriched with lipid rafts and anti-Transferrin receptor 1 (TfR1) antibodies to visualize gradient fractions containing non-raft membranes. Flotillin-1 is abundantly expressed in the brain and its selective association with raft membranes has been extensively characterized in both primary neurons and brain tissue \[[@pone.0121464.ref056]\] and thus represents a reliable marker of lipid raft enrichment. In contrast, TfR1 is excluded from lipid raft membranes under resting or stimulated conditions \[[@pone.0121464.ref057]\] in both primary cells and native tissue and thus affords a reliable indicator of non-raft membranes. We found Flotillin-1 to be consistently enriched in three buoyant gradient fractions (fractions 3 to 5; [Fig 1A](#pone.0121464.g001){ref-type="fig"}) in both mutant and wild type mouse brain whereas TfR1 appeared concentrated in heavy gradient fractions and virtually absent from buoyant, lipid raft enriched membranes ([Fig 1B](#pone.0121464.g001){ref-type="fig"}). Together, these observations indicate that DRMs purified from both Fmr1 KO and WT mouse cerebrum are overall enriched in lipid raft-associated proteins and not significantly contaminated by non-raft membranes, thus providing material of adequate purity for interrogation of the lipid raft proteome.

![Purification of lipid raft enriched membranes from wild type and Fmr1 mutant mouse brain.\
A) Schematic of isopycnic sucrose gradient used in isolation procedure of detergent resistant membranes (DRMs). Light gradient fractions containing DRMs (fractions 3 to 5) and heavy gradient fractions containing non-raft proteins are indicated. B) Representative immunoblots of extracts from WT and Fmr1 KO mouse brain illustrating isolation of DRMs used for proteomic studies. Numbers above gel lanes indicate gradient fractions (\#1, first fraction; \#13, bottom gradient fraction). Input, total homogenate; Flot-1, Flotillin-1; TfR1, Transferrin receptor 1; IB, immunoblot.](pone.0121464.g001){#pone.0121464.g001}

To systematically investigate the composition of the lipid raft proteome in Fmr1 KO mice and quantitatively compare the relative abundance of raft-associated proteins to WT mice, we used [i]{.ul}sobaric [t]{.ul}ags for [r]{.ul}elative and [a]{.ul}bsolute [q]{.ul}uantification (iTRAQ; \[[@pone.0121464.ref047]\])-based mass spectrometry ([Fig 2](#pone.0121464.g002){ref-type="fig"}). We chose iTRAQ because it affords concurrent identification and quantification of peptides in complex mixtures in solution and can be applied to purified sub-cellular fractions. Moreover, iTRAQ does not require gel matrix-based protein isolation that may compromise recovery of integral membrane proteins and hydrophobic polypeptides. Peptides differentially labeled with iTRAQ tags are chromatographically indistinguishable due to mass conservation but when fragmented by tandem mass-spectrometry analysis a balance group is released and unmasked reporter ions allow relative quantification of peaks in mass spectra.

![Workflow of iTRAQ proteomic strategy.\
Illustration of principal steps for qualitative and quantitative proteomic profiling of brain DRMs.](pone.0121464.g002){#pone.0121464.g002}

To implement iTRAQ workflow ([Fig 2](#pone.0121464.g002){ref-type="fig"}), DRM-containing gradient fractions were pooled to obtain sufficient material while decreasing individual variability: proteolytic peptides of mutant or wild type DRMs were independently labeled with different iTRAQ tags and then combined into one sample mixture that was analyzed by MS/MS. Three independent experiments were performed with mice from different litters: obtained peptide matches above identity threshold were 575 (FDR 1.22%), 796 (FDR 1.63%) and 257 (FDR 0.00%), respectively. High-confidence peptides for either genotypes identified 201, 293 and 140 protein hits from individual experiments, in good agreement with estimated raft proteome complexity of \~ 200 proteins \[[@pone.0121464.ref058], [@pone.0121464.ref059]\]. For data analysis, we combined independently obtained 2-plex datasets and compiled a list of 133 candidate proteins present in brain lipid rafts ([Table 1](#pone.0121464.t001){ref-type="table"}) that includes proteins identified in both genotypes by high confidence peptides in at least one experiment ([S1 Table](#pone.0121464.s002){ref-type="supplementary-material"}). Overall, the derived representation of the mouse brain lipid raft proteome is concordant with proteomic studies previously performed employing alternative strategies \[[@pone.0121464.ref039], [@pone.0121464.ref058], [@pone.0121464.ref060]--[@pone.0121464.ref062]\] or tissue samples including neonatal mouse brain \[[@pone.0121464.ref058]\] and human brain tissue \[[@pone.0121464.ref062]\]. To evaluate the functions associated with proteins present in the lipid raft proteome of adult mouse brain, high confidence raft proteins identified in all three experiments (85 proteins; [Table 2](#pone.0121464.t002){ref-type="table"}) were used to search the Database for Annotation, Visualization and Integrated Discovery (DAVID; \[[@pone.0121464.ref050], [@pone.0121464.ref051]\]) that allows identification of over-represented Gene Ontology (GO) terms in query protein/gene sets. Bioinformatics analysis with DAVID revealed that proteins present in brain lipid rafts were mostly associated with plasma membrane as expected ([Table 3](#pone.0121464.t003){ref-type="table"}) but also enriched at synapses and cell projections and significantly associated with heterotrimeric G protein complexes. Molecular functions ([Table 3](#pone.0121464.t003){ref-type="table"}) over-represented in the lipid raft proteome included ion and proton transport, ATPase and GTPase activity and component of myelin sheath. Moreover, brain lipid raft proteins appeared to be significantly associated with important biological processes ([Table 3](#pone.0121464.t003){ref-type="table"}) involved in neuronal function and maturation including, but not limited to, synaptic transmission and cell adhesion.

10.1371/journal.pone.0121464.t001

###### Lipid raft proteome of adult mouse brain.

![](pone.0121464.t001){#pone.0121464.t001g}

  \#        UniProtKB   Gene symbol   Gene ID   Description                                                                                                \*   \*\*   \^   \^\^   \#
  --------- ----------- ------------- --------- ---------------------------------------------------------------------------------------------------------- ---- ------ ---- ------ ----
  **1**     1433B       Ywhab         54401     14-3-3 protein beta/alpha                                                                                  √                       
  **2**     1433E       Ywhae         22627     14-3-3 protein epsilon                                                                                                             √
  **3**     1433G       Ywhag         22628     14-3-3 protein gamma                                                                                            √                  √
  **4**     1433Z       Ywhaz         22631     14-3-3 protein zeta/delta                                                                                  √    √                  
  **5**     AATM        Got2          14719     Aspartate aminotransferase, mitochondrial                                                                       √                  
  **6**     ACTB        Actb          11461     Actin, cytoplasmic 1                                                                                       √    √                  √
  **7**     ACTC        Actc1         11464     Actin, alpha cardiac muscle 1                                                                                                      
  **8**     ACTN1       Actn1         109711    Actinin-1                                                                                                                          
  **9**     ACTN2       Actn2         11472     Actinin-2                                                                                                                          
  **10**    ADT1        Slc25a4       11739     ADP/ATP translocase 1                                                                                      √    √      √           
  **11**    ADT2        Slc25a5       11740     ADP/ATP translocase 2                                                                                      √    √                  
  **12**    AGK         Agk           69923     Acylglycerol kinase, mitochondrial                                                                                                 
  **13**    AINX        Ina           226180    Alpha-internexin                                                                                                                   
  **14**    ALDOA       Aldoa         11674     Fructose-bisphosphate aldolase A                                                                                √                  
  **15**    ANS1B       Anks1b        77531     Ankyrin repeat and sterile alpha motif domain-containing protein 1B                                                                
  **16**    AT1A1       Atp1a1        11928     Na/K-transporting ATPase subunit alpha-1                                                                   √                       
  **17**    AT1A3       Atp1a3        232975    Na/K-transporting ATPase subunit alpha-3                                                                   √    √                  
  **18**    AT1B1       Atp1b1        11931     Sodium/potassium-transporting ATPase subunit beta-1                                                        √    √      √           
  **19**    ATPA        Atp5a1        11946     ATP synthase subunit alpha, mitochondrial                                                                  √           √           √
  **20**    ATPB        Atp5b         11947     ATP synthase subunit beta, mitochondrial                                                                   √    √      √           √
  **21**    BAIP2       Baiap2        108100    Brain-specific angiogenesis inhibitor 1-assoc. protein 2                                                   √                       
  **22**    BASP1       Basp1         70350     Brain acid soluble protein 1                                                                               √                       
  **23**    BSN         Bsn           12217     Protein bassoon                                                                                                        √           
  **24**    C1QBP       C1qbp         12261     Complement component 1 Q subcomponent-binding protein (mito)                                                                √      
  **25**    CA2D1       Cacna2d1      12293     Voltage-dependent Ca channel subunit alpha-2/delta-1                                                       √    √      √           
  **26**    CA2D2       Cacna2d2      56808     Voltage-dependent Ca channel subunit alpha-2/delta-2                                                                        √      
  **27**    CA2D3       Cacna2d3      12294     Voltage-dependent Ca channel subunit alpha-2/delta-3                                                                               
  **28**    CAD13       Cdh13         12554     Cadherin-13                                                                                                √                       
  **29**    CALM        Calm1         12313     Calmodulin                                                                                                                         
  **30**    CLCB        Cltb          74325     Clathrin light chain B                                                                                                      √      
  **31**    CLCN6       Clcn6         26372     Chloride transport protein 6                                                                               √                       
  **32**    CLD11       Cldn11        18417     Claudin-11                                                                                                                         
  **33**    CLH1        Cltc          67300     Clathrin heavy chain 1                                                                                     √    √                  
  **34**    CMC1        Slc25a12      78830     Calcium-binding mitochondrial carrier protein Aralar1                                                      √                       
  **35**    CN37        Cnp           12799     2\',3\'-cyclic-nucleotide 3\'-phosphodiesterase                                                                             √      
  **36**    CNTN1       Cntn1         12805     Contactin-1                                                                                                √                √      
  **37**    CNTN2       Cntn2         21367     Contactin-2                                                                                                √    √      √           
  **38**    CNTP1       Cntnap1       53321     Contactin-associated protein 1                                                                                         √           
  **39**    COX2        Mtco2         17709     Cytochrome c oxidase subunit 2                                                                             √    √                  
  **40**    COX5A       Cox5a         12858     Cytochrome c oxidase subunit 5A, mitochondrial                                                             √                       
  **41**    CSPG2       Vcan          13003     Versican core protein                                                                                                       √      
  **42**    CTNA2       Ctnna2        12386     Catenin alpha-2                                                                                            √                       
  **43**    DLG4        Dlg4          13385     Disks large homolog 4                                                                                           √                  
  **44**    DLGP3       Dlgap3        242667    Disks large-associated protein 3                                                                                                   
  **45**    DPYL2       Dpysl2        12934     Dihydropyrimidinase-related protein 2                                                                      √                       
  **46**    DYL1        Dynll1        56455     Dynein light chain 1, cytoplasmic                                                                                           √      
  **47**    ENPP6       Enpp6         320981    Ectonucleotide pyrophosphatase/phosphodiesterase member 6                                                                          
  **48**    ERC2        Erc2          238988    ERC protein 2                                                                                                                      √
  **49**    FLOT1       Flot1         14251     Flotillin-1                                                                                                √           √           
  **50**    FLOT2       Flot2         14252     Flotillin-2                                                                                                √                       
  **51**    G3P         Gapdh         14433     Glyceraldehyde-3-phosphate dehydrogenase                                                                                    √      
  **52**    GBB1        Gnb1          14688     Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1                                           √    √                  
  **53**    GBG12       Gng12         14701     Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma12                                          √                       
  **54**    GBG2        Gng2          14702     Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma2                                           √                       
  **55**    GNAI1       Gnai1         14677     Guanine nucleotide-binding protein G(i) subunit alpha1                                                     √    √                  
  **56**    GNAI2       Gnai2         14678     Guanine nucleotide-binding protein G(i) subunit alpha2                                                          √                  
  **57**    GNAO        Gnao1         14681     Guanine nucleotide-binding protein G(o) subunit alpha                                                      √    √                  
  **58**    GNAS1       Gnas          14683     Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas                                        √                       
  **59**    GNAZ        Gnaz          14687     Guanine nucleotide-binding protein G(z) subunit alpha                                                      √    √                  
  **60**    HOME1       Homer1        26556     Homer protein homolog 1                                                                                         √      √           
  **61**    HPLN1       Hapln1        12950     Hyaluronan and proteoglycan link protein 1                                                                                         
  **62**    HPLN2       Hapln2        73940     Hyaluronan and proteoglycan link protein 2                                                                                         
  **63**    HS71L       Hspa1l        15482     Heat shock 70 kDa protein 1-like                                                                                √                  
  **64**    HSP7C       Hspa8         15481     Heat shock cognate 71 kDa protein                                                                          √    √                  √
  **65**    HXK1        Hk1           15275     Hexokinase-1                                                                                                    √                  
  **66**    IGS21       Igsf21        230868    Immunoglobulin superfamily member 21                                                                                               
  **67**    IQEC1       Iqsec1        232227    IQ motif and SEC7 domain-containing protein 1                                                                                      
  **68**    IQEC2       Iqsec2        245666    IQ motif and SEC7 domain-containing protein 2                                                                                      
  **69**    KCC2A       Camk2a        12322     Ca/calmodulin-dependent protein kinase type II α sub.                                                           √           √      
  **70**    KCC2B       Camk2b        12323     Ca/calmodulin-dependent protein kinase type II β sub.                                                           √           √      
  **71**    KCC2D       Camk2d        108058    Ca/calmodulin-dependent protein kinase type II δ sub.                                                                              
  **72**    KCC2G       Camk2g        12325     Ca/calmodulin-dependent protein kinase type II γ sub.                                                           √                  
  **73**    KCRB        Ckb           12709     Creatine kinase B-type                                                                                     √                       √
  **74**    LSAMP       Lsamp         268890    Limbic system-associated membrane protein                                                                  √                       
  **75**    LY6H        Ly6h          23934     Lymphocyte antigen 6H                                                                                      √                       
  **76**    MAP1A       Map1a         17754     Microtubule-associated protein 1A                                                                          √                       
  **77**    MBP         Mbp           17196     Myelin basic protein                                                                                            √                  
  **78**    MDHM        Mdh2          17448     Malate dehydrogenase, mitochondrial                                                                        √                       
  **79**    ML12B       Myl12b        67938     Myosin regulatory light chain 12B                                                                                                  
  **80**    MOBP        Mobp          17433     Myelin-associated oligodendrocyte basic protein                                                                 √                  
  **81**    MOG         Mog           17441     Myelin-oligodendrocyte glycoprotein                                                                             √      √           
  **82**    MYH10       Myh10         77579     Myosin-10                                                                                                  √    √                  
  **83**    MYH9        Myh9          17886     Myosin-9                                                                                                                           
  **84**    MYL6        Myl6          17904     Myosin light polypeptide 6                                                                                                         
  **85**    MYO5A       Myo5a         17918     Unconventional myosin-Va                                                                                                           
  **86**    MYPR        Plp1          18823     Myelin proteolipid protein                                                                                                         
  **87**    NCAM1       Ncam1         17967     Neural cell adhesion molecule 1                                                                            √           √           
  **88**    NCAN        Ncan          13004     Neurocan core protein                                                                                                       √      
  **89**    NDUA4       Ndufa4        17992     NADH dehydrogenase 1 alpha subcomplex sub. 4                                                               √    √                  
  **90**    NEGR1       Negr1         320840    Neuronal growth regulator 1                                                                                √                       
  **91**    NEUM        Gap43         14432     Neuromodulin                                                                                               √    √                  
  **92**    NFL         Nefl          18039     Neurofilament light polypeptide                                                                                                    
  **93**    NFM         Nefm          18040     Neurofilament medium polypeptide                                                                                                   
  **94**    NTRI        Ntm           235106    Neurotrimin                                                                                                √    √                  
  **95**    ODO2        Dlst          78920     Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (mito)        √                  
  **96**    ODP2        Dlat          235339    Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (mito)                √                  √
  **97**    OMGP        Omg           18377     Oligodendrocyte-myelin glycoprotein                                                                                    √           
  **98**    PCLO        Pclo          26875     Protein piccolo                                                                                                                    
  **99**    PRIO        Prnp          19122     Major prion protein                                                                                             √                  
  **100**   RAC1        Rac1          19353     Ras-related C3 botulinum toxin substrate 1                                                                 √                       
  **101**   SCAI        Scai          320271    Protein SCAI                                                                                                                       
  **102**   SEPT7       Sept7         235072    Septin-7                                                                                                        √           √      
  **103**   SHAN3       Shank3        58234     SH3 and multiple ankyrin repeat domains protein 3                                                               √                  
  **104**   SNP25       Snap25        20614     Synaptosomal-associated protein 25                                                                         √    √                  
  **105**   SPTA2       Sptan1        20740     Spectrin alpha chain, brain                                                                                √    √                  
  **106**   SPTB2       Sptbn1        20742     Spectrin beta chain, brain 1                                                                                    √                  
  **107**   STX1B       Stx1b         56216     Syntaxin-1B                                                                                                √    √                  √
  **108**   SYGP1       Syngap1       240057    Ras GTPase-activating protein SynGAP                                                                            √                  
  **109**   SYPH        Syp           20977     Synaptophysin                                                                                                   √                  
  **110**   SYT1        Syt1          20979     Synaptotagmin-1                                                                                            √    √                  
  **111**   SYT2        Syt2          20980     Synaptotagmin-2                                                                                                                    
  **112**   TBA1A       Tuba1a        22142     Tubulin alpha-1A chain                                                                                          √                  √
  **113**   TBA1B       Tuba1b        22143     Tubulin alpha-1B chain                                                                                     √                       √
  **114**   TBA3        Tuba3a        22144     Tubulin alpha-3 chain                                                                                                              
  **115**   TBA4A       Tuba4a        22145     Tubulin alpha-4A chain                                                                                                             
  **116**   TBB2A       Tubb2a        22151     Tubulin beta-2A chain                                                                                           √                  √
  **117**   TBB3        Tubb3         22152     Tubulin beta-3 chain                                                                                       √                       
  **118**   TBB4A       Tubb4a        22153     Tubulin beta-4A chain                                                                                      √                       
  **119**   TBB4B       Tubb4b        227613    Tubulin beta-4B chain                                                                                      √                       
  **120**   TBB5        Tubb5         22154     Tubulin beta-5 chain                                                                                       √                       
  **121**   THY1        Thy1          21838     Thy-1 membrane glycoprotein                                                                                √    √      √           
  **122**   TPM3        Tpm3          59069     Tropomyosin alpha-3 chain                                                                                                          
  **123**   VA0D1       Atp6v0d1      11972     V-type proton ATPase subunit d 1                                                                           √    √                  
  **124**   VAMP2       Vamp2         22318     Vesicle-associated membrane protein 2                                                                      √    √                  
  **125**   VATA        Atp6v1a       11964     V-type proton ATPase catalytic subunit A                                                                        √      √           
  **126**   VATB2       Atp6v1b2      11966     V-type proton ATPase subunit B, brain isoform                                                              √           √           
  **127**   VATC1       Atp6v1c1      66335     V-type proton ATPase subunit C 1                                                                                √      √           
  **128**   VATD        Atp6v1d       73834     V-type proton ATPase subunit D                                                                                         √           
  **129**   VATE1       Atp6v1e1      11973     V-type proton ATPase subunit E 1                                                                                √      √           
  **130**   VATF        Atp6v1f       66144     V-type proton ATPase subunit F                                                                                                     
  **131**   VATG2       Atp6v1g2      66237     V-type proton ATPase subunit G 2                                                                                                   
  **132**   VDAC1       Vdac1         22333     Voltage-dependent anion-selective channel protein 1                                                        √    √      √           √
  **133**   VPP1        Atp6v0a1      11975     V-type proton ATPase 116 kDa subunit a isoform 1                                                           √    √      √           

(√), Identified in corresponding proteomic studies: \* \[58\], \*\* \[61\], \^ \[62\], \^\^ \[60\], \# \[39\]. List of all proteins (133) identified in DRMs from adult WT and Fmr1 KO mouse brain. List includes proteins identified in three, two or one experiment. Entry descriptors: UniProtKB, UniProt Knowledgebase database (UniProtKB/Swiss-Prot) *Mus musculus* protein entry name; gene symbol, *Mus musculus*; Entrez Gene ID, National Center for Biotechnology Information (NCBI) Entrez *Mus musculus* gene ID. Columns annotated with symbols (\*, \*\*, \^, \^\^, \#) correspond to proteomic studies listed in appended references that reported identification of the corresponding protein in lipid rafts.

10.1371/journal.pone.0121464.t002

###### Quantitative profiling of lipid raft proteome in WT and Fmr1 KO mouse brain.
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  \#       UniProtKB   Gene symbol   Entrez ID    Ave KO/WT   Sdev        ***P*-value**              Description
  -------- ----------- ------------- ------------ ----------- ----------- --------------- ---------- ---------------------------------------------------------------------------------------
  1        1433B       Ywhab         54401        0.99        0.375       0.909           ns         14-3-3 protein beta/alpha
  2        AATM        Got2          14719        1.07        0.537       0.865           ns         Aspartate aminotransferase, mitochondrial
  3        ACTB        Actb          11461        0.97        0.110       0.560           ns         Actin, cytoplasmic 1
  4        ACTC        Actc1         11464        0.99        0.124       0.758           ns         Actin, alpha cardiac muscle 1
  5        ADT1        Slc25a4       11739        0.90        0.240       0.485           ns         ADP/ATP translocase 1
  6        ADT2        Slc25a5       11740        0.95        0.254       0.712           ns         ADP/ATP translocase 2
  7        ANS1B       Anks1b        77531        1.05        0.099       0.588           ns         Ankyrin repeat and sterile alpha motif domain-containing protein 1B
  8        AT1A3       Atp1a3        232975       1.08        0.021       0.180           ns         Sodium/potassium-transporting ATPase subunit alpha-3
  9        AT1B1       Atp1b1        11931        1.22        0.601       0.591           ns         Sodium/potassium-transporting ATPase subunit beta-1
  10       ATPA        Atp5a1        11946        0.92        0.121       0.304           ns         ATP synthase subunit alpha, mitochondrial
  11       ATPB        Atp5b         11947        0.91        0.164       0.366           ns         ATP synthase subunit beta, mitochondrial
  12       BAIP2       Baiap2        108100       1.29        0.335       0.237           ns         Brain-specific angiogenesis inhibitor 1-associated protein 2
  13       BASP1       Basp1         70350        1.13        0.070       0.101           ns         Brain acid soluble protein 1
  14       BSN         Bsn           12217        1.13        0.112       0.204           ns         Protein bassoon
  15       C1QBP       C1qbp         12261        0.99        0.217       0.886           ns         Complement component 1 Q subcomponent-binding protein, (mito)
  16       CA2D1       Cacna2d1      12293        0.99        0.111       0.736           ns         Voltage-dependent calcium channel subunit alpha-2/delta-1
  17       CA2D3       Cacna2d3      12294        0.79        0.137       0.065           ns         Voltage-dependent calcium channel subunit alpha-2/delta-3
  18       CAD13       Cdh13         12554        0.93        0.130       0.376           ns         Cadherin-13
  19       CALM        Calm1         12313        0.85        0.169       0.186           ns         Calmodulin
  20       CLH1        Cltc          67300        0.92        0.205       0.479           ns         Clathrin heavy chain 1
  21       CN37        Cnp           12799        1.32        0.244       0.101           ns         2\',3\'-cyclic-nucleotide 3\'-phosphodiesterase
  22       CNTN1       Cntn1         12805        0.89        0.125       0.203           ns         Contactin-1
  23       CNTN2       Cntn2         21367        0.88        0.222       0.363           ns         Contactin-2
  24       COX2        Mtco2         17709        1.04        0.158       0.776           ns         Cytochrome c oxidase subunit 2
  25       COX5A       Cox5a         12858        1.02        0.491       0.974           ns         Cytochrome c oxidase subunit 5A, mitochondrial
  **26**   **CSPG2**   **Vcan**      **13003**    **0.82**    **0.079**   **0.031**       **\***     **Versican core protein**
  27       DLG4        Dlg4          13385        0.94        0.236       0.631           ns         Disks large homolog 4
  28       ENPP6       Enpp6         320981       1.22        0.340       0.366           ns         Ectonucleotide pyrophosphatase/phosphodiesterase 6
  **29**   **ERC2**    **Erc2**      **238988**   **1.17**    **0.066**   **0.042**       **\***     **ERC protein 2**
  30       FLOT1       Flot1         14251        0.80        0.146       0.084           ns         Flotillin-1
  31       FLOT2       Flot2         14252        1.10        0.101       0.280           ns         Flotillin-2
  32       GBB1        Gnb1          14688        0.76        0.264       0.186           ns         Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
  33       GBG12       Gng12         14701        1.29        0.860       0.608           ns         Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
  34       GBG2        Gng2          14702        1.28        0.226       0.121           ns         Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
  35       GNAO        Gnao1         14681        1.19        0.229       0.259           ns         Guanine nucleotide-binding protein G(o) subunit alpha
  36       GNAS1       Gnas          14683        1.14        0.361       0.581           ns         Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas
  37       GNAZ        Gnaz          14687        1.12        0.251       0.516           ns         Guanine nucleotide-binding protein G(z) subunit alpha
  38       HOME1       Homer1        26556        1.31        0.280       0.148           ns         Homer protein homolog 1
  39       HSP7C       Hspa8         15481        1.01        0.064       \>0.999         ns         Heat shock cognate 71 kDa protein
  40       IGS21       Igsf21        230868       1.01        0.083       0.918           ns         Immunoglobulin superfamily member 21
  41       KCC2A       Camk2a        12322        1.27        0.299       0.215           ns         Calcium/calmodulin-dependent protein kinase type II subunit alpha
  42       KCC2B       Camk2b        12323        1.24        0.365       0.343           ns         Calcium/calmodulin-dependent protein kinase type II subunit beta
  43       KCC2G       Camk2g        12325        1.21        0.331       0.362           ns         Calcium/calmodulin-dependent protein kinase type II subunit gamma
  44       KCRB        Ckb           12709        0.85        0.124       0.108           ns         Creatine kinase B-type
  45       LSAMP       Lsamp         268890       0.94        0.142       0.443           ns         Limbic system-associated membrane protein
  **46**   **LY6H**    **Ly6h**      **23934**    **0.76**    **0.020**   **0.003**       **\*\***   **Lymphocyte antigen 6H**
  47       MAP1A       Map1a         17754        1.06        0.097       0.499           ns         Microtubule-associated protein 1A
  48       MBP         Mbp           17196        1.35        0.318       0.144           ns         Myelin basic protein
  49       MDHM        Mdh2          17448        0.85        0.327       0.444           ns         Malate dehydrogenase, mitochondrial
  50       MOBP        Mobp          17433        1.47        0.345       0.089           ns         Myelin-associated oligodendrocyte basic protein
  51       MOG         Mog           17441        1.31        0.185       0.060           ns         Myelin-oligodendrocyte glycoprotein
  52       MYH10       Myh10         77579        1.02        0.245       0.966           ns         Myosin-10
  53       MYH9        Myh9          17886        1.14        0.668       0.760           ns         Myosin-9
  54       MYO5A       Myo5a         17918        1.05        0.136       0.720           ns         Unconventional myosin-Va
  **55**   **MYPR**    **Plp1**      **18823**    **1.55**    **0.176**   **0.008**       **\*\***   **Myelin proteolipid protein**
  56       NCAM1       Ncam1         17967        1.00        0.128       0.880           ns         Neural cell adhesion molecule 1
  57       NCAN        Ncan          13004        1.02        0.427       0.990           ns         Neurocan core protein
  58       NEGR1       Negr1         320840       1.01        0.209       0.980           ns         Neuronal growth regulator 1
  59       NTRI        Ntm           235106       0.97        0.101       0.566           ns         Neurotrimin
  60       ODO2        Dlst          78920        1.15        0.267       0.448           ns         Dihydrolipoyllysine succinyltransferase comp. of 2-oxoglutarate dehydrogenase complex
  61       ODP2        Dlat          235339       1.03        0.150       0.894           ns         Dihydrolipoyllysine acetyltransferase comp. of pyruvate dehydrogenase complex
  62       OMGP        Omg           18377        1.12        0.044       0.076           ns         Oligodendrocyte-myelin glycoprotein
  63       PCLO        Pclo          26875        1.08        0.015       0.140           ns         Protein piccolo
  64       PRIO        Prnp          19122        0.84        0.142       0.126           ns         Major prion protein
  65       RAC1        Rac1          19353        1.28        0.381       0.293           ns         Ras-related C3 botulinum toxin substrate 1
  66       SCAI        Scai          320271       1.46        0.971       0.471           ns         Protein SCAI
  67       7-Sep       Sept7         235072       1.45        0.272       0.052           ns         Septin-7
  68       SHAN3       Shank3        58234        1.01        0.284       0.970           ns         SH3 and multiple ankyrin repeat domains protein 3
  69       SNP25       Snap25        20614        1.10        0.551       0.800           ns         Synaptosomal-associated protein 25
  70       SPTA2       Sptan1        20740        0.97        0.157       0.681           ns         Spectrin alpha chain, brain
  71       SPTB2       Sptbn1        20742        0.97        0.099       0.530           ns         Spectrin beta chain, brain 1
  72       STX1B       Stx1b         56216        1.05        0.445       0.895           ns         Syntaxin-1B
  73       SYGP1       Syngap1       240057       1.09        0.106       0.344           ns         Ras GTPase-activating protein SynGAP
  74       SYT1        Syt1          20979        0.90        0.236       0.456           ns         Synaptotagmin-1
  75       TBA1B       Tuba1b        22143        1.21        0.155       0.113           ns         Tubulin alpha-1B chain
  **76**   **TBB2A**   **Tubb2a**    **22151**    **1.29**    **0.155**   **0.045**       **\***     **Tubulin beta-2A chain**
  **77**   **TBB5**    **Tubb5**     **22154**    **1.27**    **0.125**   **0.034**       **\***     **Tubulin beta-5 chain**
  **78**   **THY1**    **Thy1**      **21838**    **0.66**    **0.132**   **0.014**       **\***     **Thy-1 membrane glycoprotein**
  79       VA0D1       Atp6v0d1      11972        1.27        0.255       0.163           ns         V-type proton ATPase subunit d 1
  80       VAMP2       Vamp2         22318        1.12        0.715       0.810           ns         Vesicle-associated membrane protein 2
  81       VATA        Atp6v1a       11964        1.05        0.137       0.697           ns         V-type proton ATPase catalytic subunit A
  82       VATB2       Atp6v1b2      11966        1.04        0.090       0.662           ns         V-type proton ATPase subunit B, brain isoform
  83       VATE1       Atp6v1e1      11973        1.17        0.232       0.314           ns         V-type proton ATPase subunit E 1
  84       VDAC1       Vdac1         22333        1.00        0.367       0.954           ns         Voltage-dependent anion-selective channel protein 1
  85       VPP1        Atp6v0a1      11975        1.19        0.156       0.144           ns         V-type proton ATPase 116 kDa subunit a isoform 1

List of proteins (85) identified and quantified in three independent experiments in WT and Fmr1 KO brain DRMs. Numbers highlighted in bold correspond to proteins with significantly different abundance in FMR1 KO rafts. Indicated are mean ratio of Fmr1 KO *vs*. WT (KO/WT), standard deviation (Sdev) and *p*-value (t-test) in relation to internal reference (HSP7C, mean ± sdev, 1.01 ± 0.064), with *p* \<0.05 considered significant. Entry descriptors: UniProtKB, UniProt Knowledgebase database (UniProtKB/Swiss-Prot) *Mus musculus* protein entry name; gene symbol, *Mus musculus*; Entrez Gene ID, National Center for Biotechnology Information (NCBI) Entrez *Mus musculus* gene ID.

10.1371/journal.pone.0121464.t003

###### Gene ontology annotation of brain lipid raft proteome.
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  GOTERM \_CC       Term                                                             Count   \%      P value    Fold enrich.   Bonferroni   Benjamini
  ----------------- ---------------------------------------------------------------- ------- ------- ---------- -------------- ------------ -----------
  GO:0005886        Plasma membrane                                                  48      56.47   5.34E-11   2.45           1.09E-08     1.09E-08
  GO:0031225        Anchored to membrane                                             14      16.47   9.19E-10   10.07          1.88E-07     9.37E-08
  GO:0045202        Synapse                                                          13      15.29   1.18E-06   6.07           2.41E-04     3.44E-05
  GO:0005834        Heterotrimeric G-protein complex                                 6       7.06    3.17E-06   25.52          6.46E-04     8.08E-05
  GO:0042995        Cell projection                                                  16      18.82   4.84E-06   4.14           9.87E-04     9.87E-05
  **GOTERM \_MF**   **Term**                                                                                                                
  GO:0015077        Monovalent inorganic cation transmembrane transporter activity   10      11.76   4.54E-10   22.46          7.77E-08     7.77E-08
  GO:0005516        Calmodulin binding                                               10      11.76   5.16E-09   17.14          8.82E-07     4.41E-07
  GO:0015078        Hydrogen ion transmembrane transporter activity                  9       10.59   7.21E-09   21.45          1.23E-06     4.11E-07
  GO:0042625        ATPase activity, coupled to transmembrane movement of ions       8       9.41    5.06E-08   22.66          8.66E-06     1.73E-06
  GO:0003924        GTPase activity                                                  9       10.59   2.41E-07   13.74          4.12E-05     5.89E-06
  GO:0016887        ATPase activity                                                  11      12.94   1.31E-06   7.65           2.23E-04     1.86E-05
  GO:0019911        Structural constituent of myelin sheath                          3       3.5     7.49E-05   195.41         0.0127       8.53E-04
  **GOTERM \_BP**   **Term**                                                                                                                
  GO:0006754        ATP biosynthetic process                                         9       10.59   1.21E-08   20.15          9.99E-06     9.99E-06
  GO:0019226        Transmission of nerve impulse                                    12      14.12   3.04E-08   9.75           2.50E-05     8.33E-06
  GO:0015985        Energy coupled proton transport, down electrochemical gradient   7       8.24    3.97E-08   34.74          3.27E-05     4.67E-06
  GO:0007268        Synaptic transmission                                            10      11.76   4.38E-07   10.32          3.60E-04     1.80E-05
  GO:0006119        Oxidative phosphorylation                                        7       8.24    5.12E-07   22.95          4.21E-04     2.00E-05
  GO:0006812        Cation transport                                                 14      16.47   3.07E-06   4.99           0.002        1.05E-04
  GO:0007155        Cell adhesion                                                    14      16.47   7.80E-06   4.58           0.006        2.29E-04

Gene ontology (GO) terms annotation conducted with DAVID classification system (v. 6.7) using a list of proteins (85) identified and quantified in three independent experiments in WT and Fmr1 KO brain DRMs and *Mus musculus* genome reference background. Selected GO terms for Cellular Components (GOTERM_CC), Molecular Function (GOTERM_MF) and Biological Process (GOTERM_BP) over-represented in genes included in brain raft proteome. *Term*, GO term description; *Count*, number of genes annotated with a given term; *%*, percentage of genes annotated with a given term; *P value*, significance of gene-term enrichment; *Fold enrichment*, geometric mean of all the enrichment *P* values of associated terms; *Bonferroni* and *Benjamini-Hochberg*, *P*-value correction. Redundant or broad GO terms associated with many genes are not listed.

Identification of proteins differentially enriched in brain lipid rafts of Fmr1 KO mice {#sec010}
---------------------------------------------------------------------------------------

To estimate with a degree of stringency differential raft association of individual protein hits in WT v*s*. Fmr1 KO mice, we restricted quantitative analysis to those proteins for which high confidence peptides were identified in each of three independent datasets ([Table 2](#pone.0121464.t002){ref-type="table"}). We calculated for each protein a Fmr1 KO/WT ratio, with a ratio of 1 indicating no change and ratios \>1 or \<1 indicating increased or decreased raft association in Fmr1 KO brain, respectively and compared average ratios to an internal reference protein with ratio \~1 in all experiments. Although the majority of analyzed proteins appeared similarly represented in DRMs from Fmr1 KO *vs*. WT mice, seven proteins (\~8.2% of quantified proteome) displayed statistically significant (mean ± SEM, *N* = 3, *p* \<0.05) differential abundance ([Table 2](#pone.0121464.t002){ref-type="table"}). Among identified candidates, three showed decreased abundance in Fmr1 KO rafts (Lymphocyte antigen 6H, human *locus* LY6H, chromosome 8q24.3; Thy-1 membrane glycoprotein, human *locus* THY1, 11q23.3; CSPG2/Versican core protein, human *locus* VCAN, 5q14.2) whereas four were increased (ERC protein 2, human *locus* ERC2, chromosome 3p14.3; Myelin proteolipid protein/Plp1, human *locus* PLP1, Xq22; Tubulin beta-2A chain, human *locus* TUBB2A, 6p25.2; Tubulin beta 5 chain, human *locus* TUBB, 6p21.33). Interestingly, although the lipid raft proteome appeared enriched in proteins encoded by RNA transcripts that are potential FMRP targets \[[@pone.0121464.ref008]\]- 41 proteins of 133 present in the raft proteome (\~31%; [Table 4](#pone.0121464.t004){ref-type="table"})---only one, Plp1 \[[@pone.0121464.ref008]\], showed differential abundance in DRMs (\~1.2% of 85 quantified proteins).

10.1371/journal.pone.0121464.t004

###### Lipid raft associated proteins in WT and Fmr1 KO brain encoded by FMRP targets.
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  \#   Gene symbol
  ---- -------------
  1    Actb
  2    Aldoa
  3    Atp1a1
  4    Atp1a3
  5    Atp1b1
  6    Atp5a1
  7    Atp5b
  8    Atp6v0a1
  9    Atp6v0d1
  10   Atp6v1b2
  11   Bsn
  12   Calm1
  13   Camk2a
  14   Camk2b
  15   Ckb
  16   Cltc
  17   Cnp
  18   Dlg4
  19   Dlgap3
  20   Dpysl2
  21   Gnao1
  22   Gnas
  23   Gnaz
  24   Gnb1
  25   Hk1
  26   Iqsec2
  27   Mbp
  28   Myh10
  29   Myo5a
  30   Ncam1
  31   Ncan
  32   Pclo
  33   Plp1
  34   Sept4
  35   Shank3
  36   Snap25
  37   Syngap1
  38   Syt1
  39   Tubb3
  40   Vamp2
  41   Ywhag

Identified raft proteins that are encoded by RNA transcripts regulated by FMRP, based on a genome-wide HITS-CLIP study in mouse brain \[[@pone.0121464.ref008]\].

To independently validate changes in association with lipid rafts detected by iTRAQ, we examined the abundance of selected candidate proteins in extracts ([Fig 3](#pone.0121464.g003){ref-type="fig"}) or DRMs ([Fig 4](#pone.0121464.g004){ref-type="fig"}) from cortex, hippocampus and cerebellum of individual Fmr1 KO and WT mice by Western blot. We focused on candidate proteins (Ly6h, Thy1, Plp1, CSPG2) that displayed more robust changes and for which specific antibodies are available. As control, we also examined the abundance of Homer-1b/c, a scaffold protein that interacts with Gp1 mGluRs \[[@pone.0121464.ref063]\] and the expression of which was shown to be unaffected in Fmr1 KO mouse brain \[[@pone.0121464.ref064], [@pone.0121464.ref065]\]. We found that expression of Ly6h, Thy-1 and Homer-1b/c did not significantly differ between genotypes in all brain regions examined ([Fig 3](#pone.0121464.g003){ref-type="fig"}) but noted a trend to increased abundance of Ly6h in the Fmr1 KO cortex that did not achieve statistical significance (*p* = 0.1338). In contrast, Plp1 and CSPG2 showed significantly reduced abundance in Fmr1 KO mice in cortex and hippocampus, respectively ([Fig 3](#pone.0121464.g003){ref-type="fig"}). Analysis of CSPG2, which is encoded by different splice isoforms, was limited to the V3 form that could be readily detected in our conditions *vs*. other isoforms of very high molecular mass (\>400 kDa). Since Plp1 is a potential FMRP target and alterations in protein levels in Fmr1 KO mice might arise from abnormal translation of mRNAs that bind FMRP, we also examined whether an independent FMRP target---CamKIIα\[[@pone.0121464.ref066], [@pone.0121464.ref067]\]---displayed similarly altered expression and observed no significant difference in Fmr1 KO compared to WT ([S1 Fig](#pone.0121464.s001){ref-type="supplementary-material"}), in agreement with others \[[@pone.0121464.ref067]\].

![Brain expression of candidate protein hits in Fmr1 KO and WT mice.\
A) Representative immunoblots of extracts from cortices, hippocampi and cerebella of Fmr1 KO and WT mice probed with antibodies anti- Homer-1b/c (\~ 45 kDa), -Ly6h (\~15 kDa), -Plp1 (\~ 32 kDa), Thy-1 (\~ 25--37 kDa) and CSPG2 (\~ 60 kDa). Protein loading was estimated by probing with either anti-TfR1, -γTubulin, -Flotillin or---Gnb2 depending on gel separation. B) Quantification of relative abundance of indicated proteins from experiments like those in (A) measured as ratio of loading control and normalized to WT. Means ± SEM, *N* = 3 for all groups except Homer-1b/c (cortex), Plp1 and CSPG2 (hippocampus) with N = 4. Unpaired t-test, \**p* \<0.05.](pone.0121464.g003){#pone.0121464.g003}

![Abundance of candidate protein hits in DRMs of Fmr1 KO and WT mice.\
A) Representative immunoblots of combined DRM enriched fractions from individual cortices and cerebella or hippocampi pooled from two animals per group probed with antibodies anti- Homer-1b/c, -Ly6h, -Plp1 or-Thy-1. B) Quantification of relative abundance in DRMs of indicated proteins from experiments like those in (A) normalized to Flotillin content. Calculated KO/WT ratios of candidate proteins were compared to control Flotillin (KO/WT ratio, mean ± SEM 0.997 ± 0.033, *N* = 3). Means ± SEM, *N* = 3 for all groups; unpaired t-test, \**p* \<0.05.](pone.0121464.g004){#pone.0121464.g004}

Consistent with quantitative mass spectrometry, we found that Ly6h and Thy-1 abundance in DRMs was significantly reduced in the cortex of Fmr1 KO mice *vs*. WT ([Fig 4](#pone.0121464.g004){ref-type="fig"}) and observed a similar decrease in the hippocampus although in the case of Thy-1 it did not reach statistical significance (KO/WT, *p* = 0.0664). We further confirmed the presence of Homer-1b/c in lipid raft-enriched membranes with similar abundance in Fmr1 KO and WT mouse cortex and hippocampus ([Fig 4](#pone.0121464.g004){ref-type="fig"}). Whereas Ly6h is not expressed in the cerebellum \[[@pone.0121464.ref068]\], we were unable to estimate Thy-1 and Homer-1b/c abundance in DRMs from cerebellum likely due to low expression in adult animals ([Fig 3](#pone.0121464.g003){ref-type="fig"}; \[[@pone.0121464.ref069]\]). In agreement with proteomic findings, Plp1 showed significantly increased abundance in DRMs from Fmr1 KO cortices ([Fig 4](#pone.0121464.g004){ref-type="fig"}) and appeared similarly increased in hippocampus and cerebellum in which though it did not reach statistical significance. CSPG2 expression in DRMs was not examined because the molecular complexity of native Versican (the form detected by mass spectrometry) precluded accurate analysis of high molecular mass isoforms in our experimental conditions. Collectively, these observations suggest that changes in lipid raft composition are not likely to be simply dictated by protein expression levels but may instead also arise from broader cellular dysfunctions in FMRP lacking cells.

Biological networks provide a valuable framework to integrate diverse information on protein properties arising from genome-wide proteomic studies and are particularly effective in enabling association of individual proteins/genes to complex functions. To obtain information on molecular networks and pathways that might be affected by abnormalities in lipid rafts, we performed network analysis with GeneMANIA \[[@pone.0121464.ref052]\] using as query four identified candidate genes: Erc2, Plp1, Thy1 and Vcan. Tubb2a and Tubb5 were omitted from combined analysis because of their broad functionality that could skew network weight, whereas we were unable to integrate Ly6h in pathways analysis due to paucity of molecular information available for this gene. Interestingly, network analysis highlighted connections between identified genes and predicted further functional connectivity with genes encoding components of myelin sheath, axon growth cones (and terminals) and axonal processes ([Fig 5](#pone.0121464.g005){ref-type="fig"}). Altogether, our findings could inform prioritization of studies aimed to identify salient molecular and cellular dysfunctions arising from Fmr1 silencing and potentially contribute to uncovering of shared cellular pathologies between FXS and other disorders in the autism spectrum.

![Network analysis of selected proteins differentially enriched in brain lipid rafts of Fmr1 KO mice.\
Network analysis constructed with GeneMANIA using four (Erc2, Plp1, Thy1, Vcan) of seven identified genes encoding proteins differentially expressed in brain lipid rafts of Fmr1 KO mice. Connections (cellular component based) are predicted based on annotated databases and indicated by links whereby thickness conveys degree of confidence of the relationship. A) Combined network view including four query genes with selected functions highlighted in color: myelin sheath (FDR 1.13e-2), growth cone (FDR 5.89e-4), glial cell migration (FDR 7.41e-2). Additional functions include axon part (FDR 4.17e-4), calcium ion transport ((FDR 8.98e-4), regulation of synaptic transmission (FDR 4.39e-3), positive regulation of lymphocyte activation (FDR 2.2.8e-2). B, C) Network views highlighting neighbours of Thy1 (B) or Plp1 (C).](pone.0121464.g005){#pone.0121464.g005}

Discussion {#sec011}
==========

Here, we used an unbiased, genome-wide proteomic strategy to define the brain lipid raft proteome of Fmr1 knockout mice---an animal model of Fragile X syndrome---and test the hypothesis that raft association of subsets of proteins might be affected by homeostatic changes occurring in absence of FMRP. We found that whereas overall proteome representation (\~93%) is conserved, a discrete subset of proteins displays significantly altered abundance in DRMs of Fmr1 KO mice. Gene ontology and network analysis of proteins displaying abnormal abundance in absence of FMRP suggest convergence onto common cellular components and biological processes, such as axonal processes and myelination, emphasizing novel aspects of the complex biology of Fragile X syndrome and potentially other disorders in the autism spectrum.

The raft proteome shows an estimated maximum complexity of approximately 200 proteins based on studies carried out with different technologies and biological samples including HeLa cells \[[@pone.0121464.ref059]\], neonatal mouse brain \[[@pone.0121464.ref058]\] and human brain tissue \[[@pone.0121464.ref062]\]. Results from our study applying stringent criteria for protein assignment, identify 133 proteins in lipid-raft enriched membrane fractions of adult mouse brain, consistent with expected raft proteome complexity, and illustrate robust proteome coverage by iTRAQ despite incomplete peptide overlap among experiments that precluded quantitative analysis of all identified proteins. Observed variance in relative protein abundance reported by iTRAQ was modest (highest ratio difference \~1.5-fold, lowest \~0.6-fold) but of magnitude consistent with biologically relevant differences. Although iTRAQ offers a high degree of precision, it does not provide a measure of 'absolute' changes in protein abundance \[[@pone.0121464.ref047]\]: moreover, ratio compression can also arise from the fact that DRMs are a complex heterogeneous mixture of membranes extracted from different brain regions and cell types with potentially different properties.

We found that approximately 48% of the raft proteome, for which we could apply quantitation, is encoded by FMRP mRNA targets. Surprisingly, although absence of FMRP can lead to enhanced mRNA translation we found that only one identified FMRP target shows significantly increased abundance in DRMs of Fmr1 KO mice. Several mRNA targets of FMRP \[[@pone.0121464.ref008]\] encode proteins involved in lipid homeostasis, including lipid synthesis (*e*.*g*. PIGQ, FASN, SCD2, AGPAT3), metabolism (*e*.*g*. LPIN2, LPPR4, CPT1A, SMPD3), and cholesterol homeostasis (*e*.*g*. SREBF2, SCAP) and transport (*e*.*g*. LPR1, SORL1, ABCA3, LRP8). For example, PIGQ is involved in early steps of GPI anchor biosynthesis \[[@pone.0121464.ref070]\] and deficiencies in this pathway are linked to Mabry syndrome \[[@pone.0121464.ref071]\] marked by severe developmental delays and intellectual disability, autosomal recessive intellectual disability \[[@pone.0121464.ref072]\] and intractable epilepsy \[[@pone.0121464.ref073]\]. Notably, two GPI-linked proteins---Thy-1 and Ly6h ---display altered abundance in Fmr1 KO rafts, suggesting the possibility that GPI biosynthesis may be compromised in absence of FMRP. Involvement of potential dysfunctions in lipid homeostasis in FXS is further suggested by the findings that HMG-CoA reductase inhibitors that reduce cholesterol synthesis partly correct pathological dysfunctions in Fmr1 KO mice \[[@pone.0121464.ref074]\] and decrease Gp1 mGluR signaling to ERK1/2 in Fmr1 KO null neurons \[[@pone.0121464.ref057]\], lending indirect support for a potential role of the cholesterol biosynthetic pathway in FXS manifestations, at least in animal models.

An interesting observation arising from quantitative proteomics is that whereas a subset of proteins showed increased abundance in DRMs of Fmr1 KO mice, a group of proteins including Thy-1 and Ly6h displayed decreased raft association. Thy-1 is a developmentally regulated IgG-like protein enriched in neurons \[[@pone.0121464.ref075]\]. Although its precise functions and mechanisms of action remain unclear, Thy-1 was shown to inhibit neurite outgrowth and stabilize neuronal processes \[[@pone.0121464.ref076]\] *via* both cis- and trans-interactions between neuronal Thy-1 and α~V~β~3~ integrin in astrocytes, a mechanism contributing to Thy-1 impact on neurite outgrowth \[[@pone.0121464.ref077]\]. Importantly, lipid raft integrity and intact GPI anchor are required for Thy-1 actions. Thy1 knockout mice show impaired LTP in dentate gyrus \[[@pone.0121464.ref078]\] and behavioral abnormalities such as impaired social transmission of food preference \[[@pone.0121464.ref079]\] that are consistent with a critical function for this *locus* in neurodevelopment and neurodevelopmental disorders \[[@pone.0121464.ref080]\]. Ly6h, a GPI-anchored protein, is a member of the Ly6 complex---a protein family involved in immune regulation---encoded by ≥ 20 genes many of which cluster in human chromosome 8q24.3, a hot spot of deletion/duplication events linked to ASD and attention deficit hyperactivity disorder \[[@pone.0121464.ref081]\]. Ly6h expression in neurons is developmentally regulated and spatially restricted to specific brain regions (*e*.*g*. frontal cortex, hippocampus \[[@pone.0121464.ref068]\]). Although its function in the brain is unknown, the closely related Ly6/Neurotoxin 1 (Lynx1) was shown to modulate nAChRs functional properties and stabilize mature cortical networks \[[@pone.0121464.ref082]\]. Interestingly, peptides corresponding to Lynx1 were identified in DRMs by our study but not included in proteome data analysis on quality grounds. Outside the CNS, both Ly6h and Thy-1 are expressed in immune related cells including human cortical thymocytes and lymphoblastoid cell lines, suggesting the possibility that they could represent novel biomarkers for FXS and potentially other ASDs. In addition to GPI-linked proteins, another protein showing decreases raft association in Fmr1 KO mice is the versican core protein CSPG2/Vcan, a proteoglycan and a major component of extracellular matrix, with functions in cells adhesion and presynaptic maturation \[[@pone.0121464.ref083]\] among others.

Several proteins displayed increased abundance in brain rafts from Fmr1 KO mice, most prominently Plp1, an abundant component of CNS myelin, which plays a critical function in myelin formation and maintenance, oligodendrocyte development and axonal survival \[[@pone.0121464.ref084]\]. Mutations in PLP1 are linked to Pelizaeus-Merzbacher disease and spastic paraplegia (SPG2), conditions associated with intellectual disability and ASD \[[@pone.0121464.ref085]\]. Proteomic profiling also identified other protein components of the myelin sheath including CNP, MBP, MOBP and MOG all of which displayed a trend (not statistically significant) to increased abundance in Fmr1 KO rafts ([Table 2](#pone.0121464.t002){ref-type="table"}). Consistent with this, network analysis highlights myelin sheath as a potential convergent pathway for identified protein with abnormal abundance in Fmr1 KO rafts. Myelination abnormalities are detected in FXS patients \[[@pone.0121464.ref086]\] and recent evidence indicates that FMRP is expressed in oligodendrocytes \[[@pone.0121464.ref087]\] and Fmr1 KO mice display delayed myelination during development \[[@pone.0121464.ref088]\]. Together, these observations suggest that dysfunctions of myelination at the cellular and/or circuitry level may play an important and unappreciated role in pathological manifestations of FXS.

An additional subset of proteins also appeared to be modestly increased in rafts from mutant Fmr1 mice including two tubulin beta chain isoforms, encoded by Tubb5 and Tubb2a respectively, and ERC2. Tubulin has been shown to associate with lipid rafts and disruption of the microtubule cytoskeleton can lead to remodeling of raft membrane composition \[[@pone.0121464.ref053]\]. ERC2 is enriched at the presynaptic active zone and implicated in organization of the cytomatrix at synaptic terminals \[[@pone.0121464.ref089]\]: interestingly, the closely related ERC1 is associated with ASD \[[@pone.0121464.ref090]\].

The precise mechanisms underlying altered raft association in Fmr1 KO mice are at present unclear and they could involve changes in overall protein abundance or abnormalities in protein trafficking. Moreover, since DRMs are a heterogeneous mixture of membranes they do not allow to distinguish whether observed changes occur in defined cell populations and whether they are cell-autonomous or dependent on cell adhesion or trophic conditions in intact circuitry. Use of orthogonal strategies will be needed in the future to address these questions and further determine whether abnormalities in raft association reflect homeostatic adaptation in the adult brain (used in this study) and/or are present at early stages of brain development.
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###### Brain expression of CaMKIIα/β in Fmr1 KO and WT mice.

A\) Representative immunoblots of cortical extracts from WT and Fmr1 KO mice probed with anti-CaMKIIα/β and pan-β Tubulin antibodies. B) Quantification of CaMKIIα/β relative abundance from experiments like those in (A) measured as ratio of band densities for CaMKIIα/β *vs*. tubulin and normalized to WT: means ± SEM, *N* = 3, unpaired t-test, *p* = 0.157 and *p* = 0.203 for CaMKIIαand CaMKIIβ respectively.

(TIF)

###### 

Click here for additional data file.

###### List of peptides identified in WT and Fmr1 KO mouse brain.

Number of peptide matches and corresponding protein identified in three (A) two (B) or one (C) experiment. Columns E1-3 indicate number of peptide matches obtained for each protein hit: numbers in brackets indicate number of peptide used for ratio when calculated.

(XLS)

###### 

Click here for additional data file.
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